alexa
Reach Us +1-218-451-2974

GET THE APP

The Aid Of Ephedrine HCL, Curcumin And Turmerone In Neurogenesis And Inhibition Of Beta-amyloid Plaques In Transgenic Mice Models | 46229
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 2275

Journal of Alzheimers Disease & Parkinsonism received 2275 citations as per google scholar report

Journal of Alzheimers Disease & Parkinsonism peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

The aid of ephedrine HCL, curcumin and turmerone in neurogenesis and inhibition of beta-amyloid plaques in transgenic mice models

4th International Conference on Vascular Dementia

Keerthi Paramasivam

King’s College London, UK

Posters & Accepted Abstracts: J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.C1.019

Abstract
This study was done to demonstrate the effects of Ephedrine HCL, Turmerone & Curcumin in Neurogenesis and Inhibition of Beta Amyloids in Transgenic Mice. The transgenic mice models used contain mutations associated with familial Alzheimer's disease (APP Swedish, MAPT P301L and PSEN1 M146V). These mice develop age-related, progressive neuropathology including plaques and tangles. Ten-month-old male and female APPSw Tg+ and Tg− mice from 12 litters were randomly split between treatment groups. Tg+ mice were fed either chow containing a low dose of curcumin (160 ppm; n=9; a high dose of curcumin (5000 ppm; n=6), or no drug (n=8) for 6 months. Mice with low and high dose of curcumin were given specific doses of 0.02% Ephedrine HCL injection every 72 hours and underwent a single intracerebroventricular injection of 3 mg ar-turmerone. To evaluate whether curcumin treatment affected plaque pathology, cryostat hemibrain sections from Tg+ control and Tg+ low-dose curcumin-treated mice were immunostained with an antibody against Aβ1–13(DAE). Two-factor ANOVA revealed a significant reduction in plaque burden in curcumin, Ephedrine HCL and turmerone treated animals (F (1.60)=4.74; p=0.03), in which amyloid burden was decreased by 43.6% in treated animals compared with untreated animals. Soluble Aβ in Tg+ untreated and Tg+ low-dose curcumin mice were measured by sandwich ELISA. Two-way ANOVA showed significant treatment effects in decreasing the levels of soluble Aβ (*p<0.05). Underlying mechanistic pathways that might link curcumin treatment to increased cognition and neurogenesis via exon array analysis of cortical and hippocampal mRNA transcription showed a positive result.
Biography

Email: [email protected]

Top